Home / Dementia / Lowering your risk / Diabetes and weight
Dementia guide
Diabetes, weight and dementia risk
How diabetes and weight affect dementia risk, why very low blood sugar matters, and what research shows about GLP-1 drugs such as semaglutide.
Type 2 diabetes and carrying extra weight in midlife are both linked to a higher chance of developing dementia later on. The good news is that type 2 diabetes can often be prevented or delayed, and it can be managed when you have it.1,2
This page explains what the research shows, why very low blood sugar matters too, and where things stand with the popular GLP-1 drugs (such as Ozempic and Wegovy) as of October 2026.
Key points
- A major 2024 expert report lists diabetes and obesity among 14 risk factors you may be able to change. Together, these 14 factors are linked to nearly half of dementia cases.1,2
- Diabetes that starts earlier in life, lasts longer, or is poorly controlled is linked to more risk.1
- Better blood sugar control seems to help, but pushing blood sugar too low does not. Very low blood sugar is a real danger, especially for older adults.1,3
- In two large trials, the GLP-1 drug semaglutide did not slow Alzheimer's in people who already had memory problems.4,5
- Medicare pays for programs that help prevent diabetes and support weight loss. Many people pay nothing for them.6,7
How diabetes may affect the brain
Diabetes means there is too much sugar (glucose) in the blood. Over time, high blood sugar can damage organs, and the brain is one of them.2 High blood sugar may also harm the small blood vessels that feed brain cells. Damage to blood vessels is one way it may add to the risk of vascular dementia (dementia caused by reduced blood flow).
The 2024 report of the Lancet Commission on dementia (a large group of world experts) looked at the research closely. Here is what it found about diabetes:1
- Age when diabetes starts matters. In one study of about 10,000 people, each 5 years earlier that type 2 diabetes began was linked to about 24% higher dementia risk. The experts now count diabetes as a midlife risk factor.
- How long and how well controlled. Having diabetes for many years, and having blood sugar that stays high, both go with higher risk.
- Higher A1C, poorer thinking. A1C is a blood test that shows your average blood sugar over the past 2 to 3 months. In one large trial, higher A1C went along with poorer thinking skills.
These studies show a link. They cannot fully prove that diabetes causes dementia. Diabetes often comes with high blood pressure, high cholesterol and low activity, which also affect the brain. See blood pressure, cholesterol and the brain.
Does controlling blood sugar lower the risk?
The picture is mixed. The Lancet experts found that overall tighter diabetes control seems to help. But very strict, intensive control did not lower dementia risk in earlier studies.1 Aiming for "lower is always better" is not the answer.
Why very low blood sugar matters
Low blood sugar (hypoglycemia) is when blood sugar drops below a safe level. For many people with diabetes, that means below 70 mg/dL. Your doctor can tell you what is low for you.3
Low blood sugar is most common with insulin and some diabetes pills that push the body to make more insulin, such as sulfonylureas.3 Signs include shakiness, hunger, dizziness, headache, a fast heartbeat, and confusion. At night, it can cause nightmares, damp sheets, or waking up confused.3
Older adults have a higher risk of low blood sugar. So do people with kidney disease, heart disease, or memory and thinking problems.3 This can become a cycle. Memory problems make it harder to take medicine and eat on time, and lows can cause more confusion.
Call 911 if a person with diabetes passes out, has a seizure, or is too confused to eat or drink safely. Very low blood sugar can stop the brain from working properly, and it needs treatment right away.3 If the person has a glucagon emergency kit, give it if you have been taught how, then call 911.3
Never stop or change a diabetes medicine on your own. If lows are happening, or memory problems make medicines hard to manage, talk with the doctor or pharmacist. They may be able to make the plan simpler and safer.
What about specific diabetes medicines?
Some studies that followed people over time found that people taking certain newer diabetes drugs had less dementia. These include GLP-1 drugs and SGLT-2 inhibitors. People taking sulfonylureas had more dementia in those studies. Results for metformin were mixed.1
These are observational studies, not trials. People on different drugs may differ in many ways, such as age, health and access to care. So the results cannot show which medicine is best for the brain.1 The right diabetes medicine for you depends on your whole health. Talk with your doctor before changing anything.
Weight and dementia: it depends on your age
Weight seems to work differently at different stages of life.
In midlife. Across 14 studies, obesity in midlife was linked to about 31% higher risk of dementia later. A larger waist size was also linked to more risk.1
In later life. The picture flips. In an analysis of 1.3 million people, higher weight raised dementia risk when it was measured more than 15 years before dementia. But within 10 years before diagnosis, higher weight seemed to go with less dementia.1 Experts think this is because the disease itself causes weight loss years before memory problems are obvious. Being underweight (a BMI under 18.5) was also linked to more risk.1
Unplanned weight loss in an older adult is worth checking. It can be an early sign of many health problems, including dementia, depression or other illness. Tell the doctor if you or a family member is losing weight without trying. If the person already has dementia, see eating, drinking and swallowing and meals and nutrition.
Does losing weight protect memory?
We do not know yet. A review of small, short studies found that losing a modest amount (about 2 kg, or 4 to 5 pounds) went along with small gains in thinking skills. Weight loss through diet and exercise did better than weight-loss surgery.1
But in the large Look AHEAD trial of about 3,750 adults with type 2 diabetes, a long lifestyle program for weight loss did not lead to better thinking scores.1 The Lancet experts still advise keeping a healthy weight and treating obesity early, partly because it helps prevent diabetes.1
GLP-1 drugs and dementia: where the research stands
GLP-1 drugs are medicines that act like a natural gut hormone. They lower blood sugar and reduce appetite. Semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) are well-known examples. Studies of people with type 2 diabetes suggested that those on GLP-1 drugs had less dementia, which raised a lot of hope.1,5
So the drug company tested a daily semaglutide pill in two large trials, called EVOKE and EVOKE+.4
| EVOKE trials at a glance | |
|---|---|
| Who took part | 3,808 adults aged 55 to 85 with mild cognitive impairment or mild dementia due to Alzheimer's, with amyloid confirmed |
| What they took | A semaglutide pill or a placebo (a look-alike with no medicine) every day, for 2 years |
| Main result | Semaglutide did not slow the loss of memory and daily skills compared with placebo |
| Lab tests | Some blood and spinal fluid markers improved, but people still declined at the same rate |
| Safety | The drug was well tolerated, much like in earlier semaglutide studies |
Source for the table: Novo Nordisk results announcement, November 2025, and an expert review in 2026.4,5
What this means. For people who already have memory symptoms from Alzheimer's, semaglutide does not slow the disease. A 2026 review called the trials large and well run, but negative.5 The planned extra year of the study was stopped.4
What is still unknown. The review authors point out that treating Alzheimer's after symptoms start is different from preventing it. People with diabetes who have no memory problems yet are a different group. The trials do not answer whether GLP-1 drugs might help prevent dementia in them.5 For now, that is still an open question. Limited research
If you take a GLP-1 drug. These results are not a reason to stop. These medicines have proven benefits for blood sugar and weight. Talk with your doctor or pharmacist before changing anything. Read more about other drugs being tested in new treatments being tested.
What you can do
These steps are good for your heart and body, and they may help your brain too.
Prevent type 2 diabetes if you can
Strong evidenceIn a large U.S. trial, a lifestyle program cut the risk of getting type 2 diabetes by 58% over about 3 years. In people aged 60 and older, it cut the risk by 71%. The goals were to lose 7% of body weight and be active 150 minutes a week.8 Whether this also lowers dementia risk has not been proven.
Manage diabetes safely
Moderate evidenceWork with your care team on a blood sugar plan that fits your age and health. Long-term high blood sugar is linked to more risk, and so is diabetes that lasts many years.1 Ask how to avoid lows as well as highs.3
Keep a healthy weight, especially in midlife
Moderate evidenceMidlife obesity is linked to higher dementia risk.1 Small, steady changes in food and activity matter. Weight loss in later life should be planned with your doctor, not left to chance.
Move more
Moderate evidenceExercise helps blood sugar, weight and blood pressure all at once. The Lancet experts advise it for lowering dementia risk.1 See exercise for brain health.
You can also find out where you stand. More than 4 in 10 U.S. adults have prediabetes (blood sugar higher than normal, but not yet diabetes). About 8 in 10 of them do not know it.9 Prediabetes can often be reversed.9 Ask your doctor about a simple blood test.
For a daily plan that brings all the risk factors together, see keeping your brain healthy. If you live with diabetes and low mood, see depression with heart disease, stroke, diabetes and pain.
What Medicare covers
These facts are current as of October 2026. Rules can change, so check with Medicare or your plan.
- Diabetes screening. Part B covers up to 2 blood sugar tests a year, including the A1C, if you have risk factors such as high blood pressure, obesity, or a history of high blood sugar. You pay nothing if your provider accepts Medicare's rate.10
- Medicare Diabetes Prevention Program. If a recent blood test shows prediabetes and your BMI is 25 or more (23 or more if you are Asian), Part B covers a year-long program with a trained coach. It starts with 16 weekly sessions, then monthly ones. You can join in person or online. You pay nothing if you qualify.6
- Weight counseling. If your BMI is 30 or more, Part B covers counseling on diet and exercise from your primary care provider. You pay nothing if your provider accepts Medicare's rate.7
- The Medicare GLP-1 Bridge. Since July 1, 2026, this temporary program lets some people with Part D get certain weight-loss GLP-1 drugs (Wegovy, Zepbound KwikPen and Foundayo) for a $50 copay per month.11 You must meet BMI and health rules, your doctor must get approval first, and you must be in a diet and exercise program. People with type 2 diabetes are not eligible for the Bridge, but their regular Part D plan may cover a GLP-1 for diabetes.11 This program is for weight and health. It is not a dementia treatment.
Questions? Call 1-800-MEDICARE (1-800-633-4227). TTY users can call 1-877-486-2048.11
Questions to ask the doctor
Am I at risk for diabetes?
- Should I have an A1C or blood sugar test?
- Do I have prediabetes? Would a diabetes prevention program help me?
- Do I qualify for the Medicare Diabetes Prevention Program?
I have diabetes. Is my plan safe for my brain?
- What blood sugar range is right for me at my age?
- Could any of my medicines cause low blood sugar? What should I do if it happens?
- Can my medicine plan be made simpler if remembering doses is hard?
What about my weight?
- Is my weight a health concern at my age?
- I have lost weight without trying. Should we look into why?
- Would a GLP-1 drug make sense for me, and would Medicare cover it?
Sources
- Livingston G, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet, 2024. UCL accepted version (PDF)
- Centers for Disease Control and Prevention. Reducing risk for dementia. CDC, 2024. CDC
- National Institute of Diabetes and Digestive and Kidney Diseases. Low blood glucose (hypoglycemia). NIH, accessed 2026. NIDDK
- Novo Nordisk. evoke phase 3 trials did not demonstrate a statistically significant reduction in Alzheimer's disease progression. Novo Nordisk, 2025. Novo Nordisk
- Cummings JL, Scheltens P. Evoke (+) trials of semaglutide for early Alzheimer's disease: innovations, lessons, and implications. J Prev Alzheimers Dis, 2026. EM-Consulte
- Medicare.gov. Medicare Diabetes Prevention Program. Centers for Medicare & Medicaid Services, 2026. Medicare.gov
- Medicare.gov. Obesity screenings and counseling. Centers for Medicare & Medicaid Services, 2026. Medicare.gov
- National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Prevention Program (DPP). NIH, accessed 2026. NIDDK
- Centers for Disease Control and Prevention. About prediabetes and type 2 diabetes. CDC, accessed 2026. CDC
- Medicare.gov. Diabetes screenings. Centers for Medicare & Medicaid Services, 2026. Medicare.gov
- Medicare.gov. Medicare GLP-1 Bridge. Centers for Medicare & Medicaid Services, 2026. Medicare.gov
Education only. This page is general information written from the sources listed. It is not medical, legal or financial advice and does not replace a doctor, therapist or lawyer who knows your situation. How we write and check pages.
More in Lowering your risk
Related